Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea

Background. We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from a...

Full description

Saved in:
Bibliographic Details
Main Authors: Sunmin Park, Chai Hong Rim, Young Kul Jung, Won Sup Yoon
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2021/6640121
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567786593845248
author Sunmin Park
Chai Hong Rim
Young Kul Jung
Won Sup Yoon
author_facet Sunmin Park
Chai Hong Rim
Young Kul Jung
Won Sup Yoon
author_sort Sunmin Park
collection DOAJ
description Background. We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. After excluding distant and lymphatic metastases, the treatment preference for patients with a single lesion (excluding PVT (portal vein thrombosis), hepatic vessels, and bile duct invasion) and with PVT was evaluated in 7559 patients. Patients were grouped by age, and baseline liver function was divided based on the Child–Pugh class (CPC) A, B, and C. Results. For a single HCC, the majority of patients selected transarterial therapy as the initial treatment, followed by surgical resection and local ablative therapy. The surgical resection rate decreased significantly with age (p<0.001), and the transarterial therapy rate significantly increased (p<0.001). For CPC C, liver transplantation was significantly increased to 11.5%, and 36.3% of patients received no treatment. In HCC with PVT, the transarterial therapy rate was the highest, followed by the rate of abandonment of treatment. The proportion of no treatment significantly increased with age (p<0.001). In CPC C, transarterial therapy and systemic therapy were attempted in 15.4% and 5.8% of patients, respectively. Conclusions. Age and liver function have a significant impact on the therapeutic decision-making of HCC patients in Korea. In unfavorable conditions, surgical resection was less favored in patients with single tumors, and no treatment was preferred in patients with PVT.
format Article
id doaj-art-41df414eb10641e8bd8a9264244f8c7c
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-41df414eb10641e8bd8a9264244f8c7c2025-02-03T01:00:28ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972021-01-01202110.1155/2021/66401216640121Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South KoreaSunmin Park0Chai Hong Rim1Young Kul Jung2Won Sup Yoon3Department of Radiation Oncology, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of KoreaDepartment of Radiation Oncology, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of KoreaDepartment of Radiation Oncology, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of KoreaBackground. We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. After excluding distant and lymphatic metastases, the treatment preference for patients with a single lesion (excluding PVT (portal vein thrombosis), hepatic vessels, and bile duct invasion) and with PVT was evaluated in 7559 patients. Patients were grouped by age, and baseline liver function was divided based on the Child–Pugh class (CPC) A, B, and C. Results. For a single HCC, the majority of patients selected transarterial therapy as the initial treatment, followed by surgical resection and local ablative therapy. The surgical resection rate decreased significantly with age (p<0.001), and the transarterial therapy rate significantly increased (p<0.001). For CPC C, liver transplantation was significantly increased to 11.5%, and 36.3% of patients received no treatment. In HCC with PVT, the transarterial therapy rate was the highest, followed by the rate of abandonment of treatment. The proportion of no treatment significantly increased with age (p<0.001). In CPC C, transarterial therapy and systemic therapy were attempted in 15.4% and 5.8% of patients, respectively. Conclusions. Age and liver function have a significant impact on the therapeutic decision-making of HCC patients in Korea. In unfavorable conditions, surgical resection was less favored in patients with single tumors, and no treatment was preferred in patients with PVT.http://dx.doi.org/10.1155/2021/6640121
spellingShingle Sunmin Park
Chai Hong Rim
Young Kul Jung
Won Sup Yoon
Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
Canadian Journal of Gastroenterology and Hepatology
title Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
title_full Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
title_fullStr Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
title_full_unstemmed Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
title_short Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
title_sort therapeutic decision making in hepatocellular carcinoma according to age and child pugh class a nationwide cohort analysis in south korea
url http://dx.doi.org/10.1155/2021/6640121
work_keys_str_mv AT sunminpark therapeuticdecisionmakinginhepatocellularcarcinomaaccordingtoageandchildpughclassanationwidecohortanalysisinsouthkorea
AT chaihongrim therapeuticdecisionmakinginhepatocellularcarcinomaaccordingtoageandchildpughclassanationwidecohortanalysisinsouthkorea
AT youngkuljung therapeuticdecisionmakinginhepatocellularcarcinomaaccordingtoageandchildpughclassanationwidecohortanalysisinsouthkorea
AT wonsupyoon therapeuticdecisionmakinginhepatocellularcarcinomaaccordingtoageandchildpughclassanationwidecohortanalysisinsouthkorea